Insider Transactions in Q3 2023 at Inozyme Pharma, Inc. (INZY)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2023
|
Sanjay Subramanian SVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,319
+7.09%
|
$6,957
$3.57 P/Share
|
|
Aug 01
2023
|
Pivotal Bio Venture Partners Fund I, L.P. |
BUY
Open market or private purchase
|
Indirect |
833,333
+17.58%
|
$3,333,332
$4.8 P/Share
|
|
Aug 01
2023
|
Robert Lorne Hopfner |
BUY
Open market or private purchase
|
Indirect |
833,333
+17.58%
|
$3,333,332
$4.8 P/Share
|